Aging causes major alterations of all components of the neurovascular unit and compromises brain blood supply. Here, we tested how aging affects vascular reactivity in basilar arteries from young (<10 weeks; y-BA), old (>22 months; o-BA) and old (>22 months) heterozygous MYPT1-T-696A/þ knock-in mice. In isometrically mounted o-BA, media thickness was increased by $10% while the passive length tension relations were not altered. Endothelial denudation or pan-NOS inhibition (100 mmol/L L-NAME) increased the basal tone by 11% in y-BA and 23% in o-BA, while inhibition of nNOS (1 mmol/L L-NPA) induced $10% increase in both ages. eNOS expression was $2-fold higher in o-BA. In o-BA, U46619-induced force was augmented (pEC 50 $6.9 vs. pEC 50 $6.5) while responsiveness to DEA-NONOate, electrical field stimulation or nicotine was decreased. Basal phosphorylation of MLC 20 -S19 and MYPT1-T-853 was higher in o-BA and was reversed by apocynin. Furthermore, permeabilized o-BA showed enhanced Ca 2þ -sensitivity. Old T-696A/þ BA displayed a reduced phosphorylation of MYPT1-T696 and MLC 20 , a lower basal tone in response to L-NAME and a reduced eNOS expression. The results indicate that the vascular hypercontractility found in o-BA is mediated by inhibition of MLCP and is partially compensated by an upregulation of endothelial NO release.
Introduction
Aging causes major alterations of all components of the neurovascular unit, i.e. the endothelium, vascular smooth muscle and perivascular cells which include neurons and astrocytes, depending on the size of the blood vessels. 1 Several investigations implicated an increased activity of NAD(P)H oxidases (NOX) as a major cause of aginginduced alterations of cerebral blood flow. [2] [3] [4] A large body of evidence indicated that such alterations are associated with an increased risk of transient ischemic attacks, ischemic or hemorrhagic strokes, and, especially if the microcirculation is involved, dementia. 5 While at the level of the microcirculation blood flow is adapted to local metabolic demand, large cerebral blood vessels are important determinants of downstream local microvascular pressure and perfusion. 6 Thus, any dysfunction of the feed arteries will impede microvasculature perfusion. Most studies on brain perfusion focused on the vasculature that supplies the neocortex. [2] [3] [4] The basilar artery (BA), which supplies blood to the posterior circulation, i.e. the large vascular networks of the brainstem, the occipital lobes, part of the thalami and cerebellum, brain regions of vital importance, 7 appears to be understudied both clinically 8 and experimentally. 9 The territory of the posterior circulation is affected by occlusions in about 20% of all ischemic strokes 10 and transient ischemic attacks. 8 An important clinical aspect regarding the posterior circulation is its flow plasticity, which allows bidirectional flow through the numerous collaterals of this vessel network 9 , rendering the clinical symptoms highly diverse. 11 Despite its rarity (under 5% of all cases) and the recent therapeutic advances, acute flow impairment in the BA territory has still devastating consequences for the patients, with calculated 80%-90% mortality or disability rates, 12, 13 and as yet there are no clear evidence-based therapeutic guidelines. A novel experimental therapeutic approach in animal models is the stimulation of the sphenopalatine ganglion 14 which leads to vasodilation, likely by releasing NO from perivascular neurons. 15, 16 Histological and electrophysiological studies have demonstrated that cerebral arteries are innervated predominantly by preganglionic neurons originating from the superior salivatory nucleus, which via the great petrosal nerve and sphenopalatine ganglion, and after switching to small postganglionic neurons, innervate cerebral arteries and intracranial internal carotid arteries, as well as the vasculature of the lacrimal and nasal glands. 17 These neurons release NO and peptides like substance P, vasoactive intestinal polypeptide and calcitonin gene-related peptide. Others display cholinesterase expression. 17 Transmural electrical (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) or chemical (nicotine) stimulation relax different cerebral vessels in a variety of species in vitro (as reviewed in Toda and Okamura 18 ). The responses were selectively blocked by hexamethonium, tetrodotoxin and NOS inhibitors, suggesting the involvement of small perivascular nitrergic neurons. [19] [20] [21] [22] [23] [24] The contribution of peptide neurotransmitters and of cholinergic nerves to neuronally mediated vasodilation is still unclear. 23 Pharmacological studies revealed that about twothirds of NO originated from perivascular nerves and one-third from non-neuronal tissues, mainly the endothelium, a stoichiometry that likely also applies to humans. 17 This stoichiometry of constitutive NO-production seems to be changed with senescence. For example, the vasodilatory response of brain vasculature to systemic application of nicotine is blunted in aged rats. 25 Furthermore, NO liberated from the endothelium, but not from nNOS or iNOS, appears to be the predominant protective mechanism against cerebral ischemia and hypoperfusion in aged rats. 26 To date, little is known how old age affects these responses in basilar arteries, especially in the mouse, which is widely used as small animal model for cerebral vascular dysfunction. 27, 28 Also, little is known how old age ($2 years) of mice affects basal NO release, a major regulator of vascular tone and, hence, cerebral blood flow 29 as most investigations studying aging effects use only one-year-old animals. 2, 4 However, old age (>20 months) changed the reactivity compared to oneyear-old animals. 3, 30 Here, we investigated vascular reactivity of BA in 22-24 months old mice, which are close to the end of their life, and, hence are more representative than oneyear-old mice of senescent humans. The goals of our study were (i) to investigate whether there is evidence for neuronally released NO by using electrical field stimulation (EFS) and inhibitors of eNOS and nNOS and whether this is affected by aging; (ii) we have previously shown 31 that in young rat vessels, the responsiveness to the thromboxane analogue U46619 is blunted in a NOdependent manner. Because of the known endothelial dysfunction in aging, we hypothesized that aged vessels are hyperreactive to U46619, (iii) that the augmented basal tone previously described in aged pressurized rat middle cerebral artery 30 involves inhibition of MLCP mediated by phosphorylation of its regulatory subunit, MYPT1 and (iv) that the aging-induced changes in regulation of vascular tone are amenable to apocynin.
Materials and methods
The mice were kept in the Animal Facility of the 
Mechanical experiments
Dissection and mounting of mouse basilar arteries. Male C57/BL6NCr mice were sacrificed after isoflurane narcosis by cervical dislocation. The basilar arteries of 8-10 week (y-BA) and 22-24 months old mice (o-BA) were isolated at room temperature in physiological salt solution (PSS) containing in mmol/L: NaCl 119, KCl 4.69, MgSO 4 1.17, KH 2 PO 4 1.18, NaHCO 3 25, EDTA 0.03, glucose 5.5, CaCl 2 0.16 aerated with carbogen. Then, 1.8-2.0 mm long-ring segments were mounted with 25 mm tungsten wires in a wire-myograph (model 300A or 610A, DMT myotechnology, Denmark). Following mounting, CaCl 2 was increased to 1.6 mmol/ L, and temperature was raised to 37 C. For investigations without functional endothelium, arteries were mechanically de-endothelialized using mouse whiskers. After equilibration, the arteries were stretched to their optimal diameter using the so-called normalization protocol according to the manufacture's instruction and the DMT software (cf. also Mulvany and Halpern 32 , Supplementary Figure 1 ). Initial force between groups immediately (2 min) after the normalization procedure was not different (2.2 AE 0.08 mN in n ¼ 8 y-BA with intact endothelium vs. 2.2 AE 0.1 mN in n ¼ 5 de-endothelialized preparations; 2.2 AE 0.07 mN in n ¼ 8 o-BA with intact endothelium vs. 2.5 AE 0.1 mN in n ¼ 5 de-endothelialized preparations, all p < 0.5). This force converts into a calculated pressure of $6.5 kPa, which corresponds to the in vivo carotid artery blood pressure. 33 Experimental protocols U46619 dose-response curves. The vessels were activated by cumulatively adding U46619 to the organ bath (concentration range 0.01 to 3 mmol/L). To test for NOmediated modulation of contractile activity, a second dose-response curve was obtained after pre-incubation for 20 min with L-NAME (100 mmol/L) or L-NPA (1 mmol/L) or vehicle (H 2 O; time-matched controls).
In some experiments, the arteries were incubated with the inhibitors immediately after the normalization procedure to test for development of basal tone. Basal tone was always expressed in % of the subsequent force elicited by maximal concentration of U46619.
Transmural EFS. The vessels were electrically stimulated with a home build device via two platinum wires placed in parallel to the long axis of the arteries with unipolar rectangular 0.1 ms pulses. After determining the voltage necessary for maximal relaxation (Supplementary Figure 6 ), frequency response curves with supramaximal (30 V, train duration 3 s) and submaximal (12.5-17.5 V, train duration 20 s) stimulation were obtained. Submaximal EFS was chosen to analyze the NOS dependence of the initial fast phase (cf. Supplementary Methods and Supplementary Figure 6 ). Relaxation by EFS or nicotine was expressed as % force of the submaximal U46619-induced force, i.e. (force(EFS)/ U46619-induced force Â 100).
Staphylococcus aureus -toxin permeabilized vessels. Arteries were permeabilized before mounting on the myograph as described. 34 The mounted preparations were stretched to their optimal lumen diameter. Submaximal contractions were elicited by pCa 6.1 for 15 min followed by maximal activation with pCa 4.3 (cf. Supplements).
Determination of media thickness
The media thickness of isometrically mounted and pre-stretched preparations (endothelium intact) was estimated from confocal Z-stack images of Alexa Fluor Õ 555 phalloidin-stained vessels as detailed in the Supplementary Information.
eNOS and nNOS expression
BAs were isolated as for mechanical experiments and shock frozen in liquid nitrogen. Total RNA was extracted with Maxwell 16 LEV simplyRNA kit (Promega, Madison, WI), and the amount of RNA was quantified. RNA was then reverse transcribed into cDNA (cDNA-kit, QuantiTec, QIAGEN). The real-time PCR was carried out with a GoTaq Õ qPCR Master Mix (Promega, Madison, WI) and was run in a thermocycler (StepOnePlus TM real-time PCR System, Applied Biosystems TM ). Data analysis was achieved by StepOne Software v2.3.
Protein phosphorylation
Protein phosphorylation was determined by western blot analysis 34 (cf. Supplementary Methods). In brief, endothelium-intact vessels were mounted on a 25-mm tungsten wire, incubated for 15 min either with vehicle (0.2% DMSO) or 600 mmol/L apocynin, then shock frozen and processed for western blotting. Primary antibodies were directed against phospho-MLC 20
Ser19
, phospho-MYPT1 T-853 or phospho-MYPT1 T-696 . Detection and quantification of immunoreactive signals were performed using the Odyssey system (LiCor).
G-actin content
G-actin content was determined using ''G-actin/F-actin In Vivo Assay Kit'' (Cytoskeleton/Biomol). Briefly, BAs from both age groups ($4 mm long) were isolated as described above, shock frozen in liquid nitrogen, and further processed according to the manufacturer's instructions (cf. Supplementary Methods).
Gene targeting of MYPT1
A point mutation was introduced into the regulatory subunit of MYPT1 by gene targeting (knock-in) in the mouse replacing the inhibitory phosphorylation site T-696 by the non-phosphorylatable alanine (see Supplementary Methods for details). No homozygous offspring were obtained; however, heterozygous offspring were viable with no overt phenotype and reached old age. A detailed description of this mouse model will be published elsewhere.
Statistics
Data were summarized as mean and standard error (SEM). Figure groups and the experimental design groups were compared using two-sample t-test for independent samples or one-way ANOVA followed by appropriate post hoc tests (Tukey, Bonferroni or Dunnett, respectively). In case of 2 Â 2 factorial designs, main effects as well as interactions between the factors were investigated using two-way ANOVA. A p value of <0.05 was considered statistically significant. GraphPad Version 4 (GraphPad Software, San Diego, USA) and IBM-SPSS Statistics Version 23 (Armok, NY) were used to perform statistical analyses.
Results

Modulation of U46619-induced and basal tone by nNOS inhibition in young and old murine basilar arteries
Passive force following the normalization protocol ($2.2 mN, cf. Methods) and the slope of the pressurediameter relation were not different between groups indicating similar passive properties (Supplementary Figure 1 ). However, U46619-induced force was significantly blunted in young vessels from $2-monthold mice compared to 22-24 months old mice ( Figure 1 ). Thus, F max was 1.8 AE 0.2 mN (n ¼ 15) in y-BA compared to 3.5 AE 0.4 mN in o-BA (n ¼ 10, p < 0.001), and pEC 50 was 6.5 AE 0.1 in y-BA versus 6.9 AE 0.1 in o-BA (p < 0.01, Figure 1 , Table1). The difference in F max remained when wall tension and wall stress were calculated taking into account the differences in segment length and the $10% thicker media in o-BA (cf. Supplementary Figure 1 ).
Pre-incubation with L-NAME significantly increased F max and pEC 50 in y-BA versus time control ( Figure 1 and Table 1 ) as has been found previously in cerebral vessels from young rats. 31 In contrast, the L-NAMEinduced leftward shift of the dose-response relation was smaller in o-BA (Table 1) . As L-NAME inhibits both eNOS and nNOS, the experiments were repeated in the presence of L-NPA (1 mmol/L), which at this concentration is a rather specific inhibitor of nNOS. 32 As depicted in Figure 1 , L-NPA shifted the U46619 doseresponse curves in y-BA by a similar extent as L-NAME (cf. Table1). No significant changes in the concentrationresponse curves were observed in time-matched controls ( Table 1 ). The ET A receptor antagonist, BQ123 had no Control refers to first dose-response relation, time control (t.c.) to second dose-response relation in the absence of inhibitors. F max : Young: **t.c. vs. L-NAME p < 0.01; *t.c. vs. L-NPA p < 0.05; L-NAME vs. L-NPA or vs. BQ123þL-NAME p> 0.05; Old: § § § Controls (old) vs. Controls (young) p < 0.001; F max (old) no significant difference between groups (p > 0.05).pEC 50 : Young: **t.c. vs. L-NAME or L-NPA p < 0.01; L-NAME vs. L-NPA or vs. BQ123þL-NAME p > 0.05; Old: pEC 50 (old) no significant difference between groups (p > 0.05); pEC 50 (old) vs. pEC 50 (young) p < 0.01. ÁpEC 50 : Young: **t.c. vs. L-NAME p < 0.01; *t.c. vs. L-NPA p < 0.05; L-NAME vs. L-NPA or vs. BQ123þL-NAME p > 0.05; Old: *L-NAME (old) vs. L-NAME (young) p < 0.05; L-NAME (old) vs. L-NPA (old); p > 0.05; L-NAME (old) vs. BQ123þL-NAME (old) p > 0.05; L-NAME (old) vs apocynin þ L-NAME (old); p > 0.05. Basal tone: *L-NAME (old) vs. L-NAME (young) p < 0.05. significant effect on U46619 dose-response curves with and without L-NAME (cf. Table 1 and Supplementary  Figure 2 ) indicating that the increased responsiveness to U46619 after inhibition of NOS by L-NAME was not due to endothelin release.
Both NOS inhibitors also raised basal tone, whereby L-NPA appeared to be equally effective as L-NAME in y-BA and o-BA (Table 1 , p ¼ 0.45). In contrast, L-NAME induced a significantly larger basal tone increase in aged compared to y-BA (p < 0.05).
Incubation with BQ123 did not affect the L-NAMEinduced raise in basal tone (see Table1, Supplementary Figure 2 ). Our results are consistent with the hypothesis that in y-BA, NO was liberated from non-endothelial rather than endothelial sources, whereas in o-BA, endothelial-derived NO significantly contributed to maintenance of basal tone. This notion is supported by the finding that basal tone gradually increased in mechanically de-endothelialized preparations after the normalization procedure (Figure 1(e) ). Interestingly, inhibition of L-NPA was additive to mechanical denudation in y-BA ( Supplementary Figure 3) .
Consistent with the mechanical observations, we found a $2-fold higher eNOS expression in o-BA (n ¼ 7) compared to y-BA (p < 0.05; n ¼ 7; Figure 1 (f)). No significant increase in nNOS-mRNA (p > 0.05, n ¼ 5) was observed. We are aware that the comparison was underpowered due to the low n-number because of the limited availability of aged mice. Of note, eNOS but not nNOS mRNA could be detected in peripheral arteries while expression of nNOS but not of eNOS was high in gastric fundus as expected. This indicates differences in the source of NO (endothelial versus non-endothelial) between cerebral and peripheral arteries.
Relaxation of U46619 pre-contracted arteries by transmural EFS: Effect of apocynin
The results presented in Figure 1 indicated that nonendothelial NO release modulates resting and U46619 elicited contraction. Putative sources are besides endothelial and adventitial cells, 35 perivascular neurons. 36 As EFS has been shown to release NO from such neurons, 18 we next tested whether transmural EFS relaxed U46619 pre-contracted BA in a NO-dependent manner.
As shown in Figure 2 , EFS (supramaximal voltage) relaxed both y-BA and o-BA in a frequency-dependent manner similar to a previous report in rat brain arteries. 37 Relaxation was biphasic consisting of an initial fast and subsequent slow phase and was maximal at 10 Hz (Figure 2 and Supplementary Figure 6 ) while 30 and 100 Hz induced a transient contraction.
In endothelium-intact preparations, EFS-induced relaxation at 10 Hz was similar in both age groups (p > 0.05, Figure 2 (e) and (f)). Endothelial denudation attenuated EFS-induced relaxation in o-BA (Figure 2(f) ) but not in y-BA (Figure 2(e) ). This indicates that in aged but not in y-BA, endothelium modulates EFS-induced relaxation.
To further characterize EFS-induced relaxation, endothelium-denuded BAs were subjected to EFS with submaximal voltage (12.5-17.5 V) which triggered only the initial fast relaxation (Figure 3 Figure 6 ). At 10 Hz, EFS-induced relaxation was 11.8 AE 2% in o-BA (n ¼ 5), which was significantly different from that induced by submaximal voltage in y-BA (25 AE 2%, n ¼ 8, p < 0.05). To test that EFS-induced relaxation involves neuronally released NO, young vessels were pre-incubated with TTX (1 or 10mmol/L) and L-NPA (3mmol/L) before eliciting a original force tracings) indicating that relaxation involves neuronally released NO. EFS-induced relaxation was not affected by either compound in o-BA (Figure 3(d) ). At the end of most experiments, the preparations were additionally challenged with nicotine (100 mmol/L). The amplitude of nicotine-induced relaxation was similar to that induced by EFS (10 Hz) in y-BA consistent with other reports 16 and was significantly (p < 0.001) smaller in o-BA (Figure 4(a) ). In y-BA, nicotine-induced relaxation was significantly attenuated by TTX or L-NPA (p < 0.05, Figure 4(a) ). We hypothesized that the attenuated relaxation of o-BA might be due to higher pre-contraction (force in % F max : time control y-BA 79 AE 4 (n ¼ 6) versus o-BA 89 AE 3 (n ¼ 5)). Therefore, we reduced U46619 to 0.1 mmol/L (denoted as normalized time control in Figure 3(d) ) which lowered submaximal force to 68 AE 4% compared to 89 AE 3% at 0.3 mmol/L U46619, and which was not different from the time control in y-BA (p > 0.05). However, lowering of U46619 concentration did not restore EFS-or nicotine-induced relaxation.
We then hypothesized that the attenuated relaxation in o-BA was due to ROS generation and therefore tested whether apocynin would restore relaxation. Apocynin significantly enhanced nicotine-induced relaxation in o-BA (p < 0.01; Figure 4 (a) and (c)) to levels that were not significantly different from y-BA with and without apocynin. Apocynin did not enhance the nicotine-induced relaxation in young arteries (p ¼ 0.14). It had no effect on U46619 dose-response relation in o-BA (Table 1 ) and on EFS-induced relaxation in both age groups (Figure 4 (b) to (d)).
Effect of apocynin on NO-mediated relaxation in aged arteries
The attenuated relaxation may be caused by impaired release of NO or by attenuated responsiveness of vascular smooth muscle cells to NO. To distinguish between these possibilities, endothelium-intact BAs pre-constricted with U46619 (0.3 mmol/L) in the presence of L-NAME were incubated with increasing concentrations of DEA-NONOate. The dose-response curve to DEA-NONOate was shifted to the right towards higher concentrations in old compared to y-BA (Figure 4(e) , p ¼ 0.014). To test whether apocynin restored DEA-NONOate sensitivity, y-BA and o-BA were pre-incubated with apocynin in the presence of L-NAME (15 min alone and another 20 min together with L-NAME) followed by stimulation with 0.3 mmol/L U46619 in the continuous presence of the compounds. Apocynin had no effect on submaximal tone in both age groups ( Supplementary Figure 4 , p > 0.05). Apocynin had no effect on the dose-response curve to DEA-NONOate in y-BA but in o-BA it was shifted to the left towards that obtained in y-BA (Figure 4(e) ). Thus, the response to 100 mmol/L DEA-NONOate was significantly (p < 0.05) smaller in o-BA compared to y-BA in the absence but not in the presence of apocynin. We then tested whether apocynin prevented the L-NAME-induced increase in basal tone in o-BA (Figure 4(f) ). As depicted in Figure 4(f) , L-NAME-induced force in the presence of apocynin in o-BA was comparable to that in y-BA in the absence of apocynin (p >0.05). Different from the experiments shown in Figure 1 , the vessels were not stimulated with U46619 prior to incubation with L-NAME which may account for the larger increase in tone.
Aging is associated with increased basal MLC 20 and MYPT1 phosphorylation and increased F-actin content
We next investigated whether there was a difference under resting conditions in MLC 20 phosphorylation at S-19, the site that is responsible for activation of myosin ( Figure 5(a) ). As depicted in Figure 5 (b), resting MLC 20 phosphorylation was significantly higher in o-BA compared to y-BA (p < 0.01), and apocynin decreased MLC 20 in o-BA significantly (p < 0.01) to levels that were not different from those in y-BA (p > 0.05). Further phosphorylation of the regulatory subunit of myosin phosphatase, MYPT1 at T-853 was significantly higher in old compared to y-BA ( Figure 5(b) ). In contrast, phosphorylation of T-696 was high in both age groups ( Figure 5(b) ). Apocynin significantly decreased phosphorylation of T-853 in both ages and of T-696 in y-BA. Dephosphorylation of T-696 by apocynin in o-BA did not reach the level of significance (p ¼ 0.048). Taken together, these results suggest that MLCP is inhibited in o-BA. In keeping with this notion, basal Ca 2þ -sensitivity, i.e. in the absence of Ca 2þ -sensitizating agonists, was increased in a-toxin permeabilized o-BA ( Figure 5(c) ). Moreover, the increased T-853 phosphorylation suggests increased ROK activity in o-BA and requires to be tested further in the future. Augmented ROK signaling has been shown to reduce G-actin content in cerebral arteries. 38 In line with this we found that fluorescence intensity of Alexa Fluor Õ 555-phalloidin was enhanced in confocal images of o-BA, indicating an increased F-actin fraction ( Figure 5(d) ). This notion was corroborated by biochemical analysis of the G-actin to F-actin ratio which was significantly lower in o-BA ( Figure 5 
Role of inhibitory MYPT1-T-696 phosphorylation in aged arteries
The impact of T-696 phosphorylation on basal tone in o-BA was tested in heterozygous aged T-696A/þ knock-in mice, in which T-696 was exchanged by alanine, which cannot be phosphorylated. This resulted in a $40% reduction in phosphorylation of T-696 in the mutant compared to WT mice. MLC 20 phosphorylation was reduced to that in young mice (Figure 6 (b) and cf. Figure 5(b) ). Basal tone in the presence of L-NAME was 14.6 AE 3.9% in mutant o-BA compared to 23.0 AE 1.2% (n ¼ 5, p < 0.05). It was comparable to the values in WT y-BA (11.0 AE 2.1; p ¼ 0.35; n ¼ 9; Figure 6(c) ). Interestingly, expression of eNOS was reduced in old mutant compared to old WT mice (p < 0.05, Figure 6(d) ).
Discussion
The major finding of this work is that in mouse BA, aging shifted both basal and stimulated NO release from predominantly non-endothelial, likely neuronal, towards mainly endothelial sources. This shift correlated with a $2-fold upregulation of eNOS expression. Chemical inhibition or mechanical denudation of the endothelium unmasked an augmented basal smooth muscle tone in o-BA which can be ascribed to a ROS-mediated inhibition of MLCP. We provide evidence that phosphorylation of MYPT1-T-696 plays an important role in the regulation of basal tone in o-BA, and in eNOS expression to our knowledge for the first time. The resting pressurediameter relation of endothelial-intact arteries was not different between young and o-BA, indicating that the balance between vasodilatory and vasoconstricting signaling molecules is maintained, though at higher absolute levels. Thus, virtually all components of the neurovascular unit, i.e. endothelial and smooth muscle cells as well as perivascular neurons are altered by aging. 
Basal NO release in aging
It is well known that basal NO release is the major regulator of cerebral blood flow/vascular tone. 29 This is supported by our results where chemical inhibition of NOS or mechanical denudation of the endothelium increased basal tone in both age groups. The novel finding is that non-endothelial sources contribute significantly to basal NO liberation in y-BA. The arguments are (i) in y-BA chemical inhibition of nNOS appeared to be more effective than endothelial denudation in raising basal tone (Figure 1(e) ; Table 1 ) and (ii) chemical inhibition of nNOS was additive to endothelial denudation and raised basal tone in y-BA up to levels observed in o-BA ( Supplementary Figure 3) . Our results are corroborated by the immunohistochemical detection of nNOS in endothelial and adventitial cells 35 and in perivascular neurons of cerebral blood vessels. 36 In o-BA, the endothelium appeared to be the more important source of basal NO release, opposing the augmented/enhanced smooth muscle tone as indicated by the similar passive force of endothelium-intact young and aged vessels ( Supplementary  Figure 1(d) ). Interestingly, if smooth muscle tone in o-BA was lowered to that in y-BA, as it was the case in o-BA from MYPT1-T696A/þ mice, then the eNOS expression was also decreased. The elucidation of the underlying mechanism for this novel and interesting observation is currently under investigation.
The finding of a shift towards predominantly eNOS regulation of cerebral vascular tone in aged vasculature is not novel. Increased reactivity toward NOS inhibitors has been reported for aged pressurized rat middle and posterior cerebral arteries. 30, 39 As endothelium denudation completely eliminated aging-related differences in development of myogenic tone, authors concluded that aging was associated with down-regulation of an endothelial, NOS-insensitive, mechanism, which was compensated by upregulation of NO release from the endothelium. 30 Contrary to this report, endothelial denudation did not abrogate the age-dependent differences in our experiments. Therefore, endothelial release of non-NO signaling molecules appears to be of minor functional importance in our preparation.
Stimulated NO release in aging
There is a large body of evidence that electric stimulation relaxes cerebral arteries by release of NO from perivascular nitrergic neurons (as reviewed in Toda and Okamura 18 ). Our observations that transmural electric stimulation resulted in an endothelium-independent relaxation in y-BA, that was inhibited by L-NPA and TTX and was mimicked by nicotine, are consistent with these published results. Also, and consistent with previous reports, 21 electrically and chemically (nicotine) induced relaxation was independent of an intact endothelium in y-BA. In contrast, mechanical denudation attenuated EFS-induced relaxation at supramaximal voltage. Relaxation induced with submaximal voltage or EFS was also nearly abrogated in endotheliumdenuded, o-BA. Thus, it appears that nNOS efficiency is significantly reduced in aged murine BA, which is consistent with a previous report on middle cerebral arteries in spontaneous hypertensive rats. 35 These authors also detected no change in nNOS immunoreactivity, which is in an agreement with our finding that nNOS expression was not increased (Figure 1(f) ). Apocynin treatment did not restore the attenuated vascular response to EFS in our model, suggesting that nitrergic neurons may be lost or undergo functional silencing with advanced age, perhaps due to ROS accumulation. 3 A limitation is that some of the experiments in old animals were underpowered. This was due to the limited number of aged mice and requires further studies. Nevertheless, our results indicated that there are differences in the importance of the endothelium between young and old animals. Our experiments further suggest that the lowered nNOS efficiency in o-BA was compensated by the endothelium. Electrically induced, endothelial-dependent relaxation has been reported in some but not all species, and has been suggested to be due to release of vasoactive peptides, acting on the endothelium to release NO. 40 Alternatively, EFS may trigger endothelial Ca 2þ influx (agonist-induced Ca 2þ -pulsars) followed by activation of K Ca 2.3 or K Ca 3.1 channels. The ensuing membrane hyperpolarization spreads to the vascular smooth muscle cells, leading to closure of voltage-gated Ca 2þ -channels and, thus, to relaxation. [41] [42] [43] In agreement with our previous report, 31 we found that the contractile response to the thromboxane analogue U46619 was significantly attenuated in young vessels, and that the inhibition of nNOS by L-NPA potentiated the contractile response. As ThromboxaneA 2 -receptors have been identified in neurons and glial cells, 44 this raises the intriguing possibility that U46619, like nicotine, stimulates NO release from nitrergic neurons thereby braking its own contractile action. However, we cannot exclude the possibility that inhibition of NOS disinhibits a constrictor response. We consider this less likely because we have previously shown using cerebral arteries from young rats, 31 that U46619 not only activates the RhoA/ ROK calcium-sensitization pathway but in parallel also the NO/cGMP/PKG calcium-desensitization pathway thereby blunting the contractile response in a L-NAME sensitive manner. Moreover, blocking ET A receptors had no effect on U46619 dose-response relations nor on basal tone. In any case, the ''autoinhibitory'' effect of U46619 was significantly attenuated in o-BA and is not compensated by the upregulation of endothelial NO production. This finding could be explained by a preferential action of U46619 on perivascular neurons over endothelial cells. Taken together, aging is associated with a diminution of NO released from non-endothelial sources, likely perivascular neurons, which are compensated for by an upregulation of endothelial-derived NO.
Smooth muscle hypercontractility in aging
Endothelial denudation and chemical inhibition of NO-signaling unmasked the smooth muscle hypercontractile state in o-BA. The underlying cause for the hypercontractile state may be an increased Ca 2þsensitivity, as suggested by Geary and Buchholz 30 for pressurized middle cerebral arteries and, to the best of our knowledge, directly evidenced for the first time in the present work: We used a-toxin permeabilized BA ( Figure 5(c) ). This procedure that short-circuits ion fluxes through the membrane allows for precise control of sarcoplasmic calcium ([Ca 2þ ] i ), while leaving Ca 2þsensitizing signaling cascades functionally intact. 45 We ascribe the increased Ca 2þ -sensitivity to the increased basal phosphorylation of the regulatory subunit of myosin phosphatase, MYPT1 at T-853, the site that is phosphorylated by ROK, which leads to a reduction in myosin phosphatase (MLCP) activity. 46 The decreased MLCP activity then leads to the observed increased MLC 20 phosphorylation at a given level of Ca 2þ -activation, i.e. an increase in Ca 2þ -sensitivity of contraction. 47 All these events, increased tone, phosphorylation of MLC 20 at S-19 and phosphorylation of MYPT1 T-853 can be reversed by functional elimination of ROS by apocynin ( Figure 5(a) and (b) ). Furthermore, apocynin also decreased the high levels of MYPT1-T-696 phosphorylation, especially in young animals, and restored the impaired smooth muscle sensitivity to NO in aged animals (Figure 4(e) ). Lowering of NO sensitivity, paralleled by a decreased serum antioxidant capacity, has recently been reported in BA in a rat aging model, corroborating our notion that aging increased ROS production impedes NO/cGMP-mediated relaxation. 48 There is a large body of evidence for redox regulation of Rho/ROK signaling which alters the inhibitory phosphorylation sites of MLCP [49] [50] [51] and cerebrovascular aging is associated with a loss of antioxidant capacity, 48 and peroxynitrite formation 52 linked to an increased eNOS expression, 52, 53 as well as enhanced NADPHderived ROS production in neurons and blood vessels. 3 More recently, evidence is emerging that augmented procontractile endothelin-1/G 12/13 signaling drives constriction of aged peripheral arteries. 54, 55 Contrary to these observations in peripheral arteries, basal tone of o-BA was not affected by the ET A receptor antagonist BQ-123. It is noteworthy that apocynin, which has been widely used as a non-specific NAPDH oxidase inhibitor, 56 inhibits also ROK. 57 Thus, the reduction in basal tone and in MYPT1-T853 phosphorylation might be related to the latter effect. Nevertheless, the increased MYPT1-T853 phosphorylation is evident for an augmented Rho/ ROK signaling to which ROS and ET-1 signaling converge.
Interestingly, phosphorylation of MYPT1-T-696, which directly inhibits MLCP activity (reviewed in Puetz et al. 47 ), was high in both age groups and was less affected by apocynin than T-853 phosphorylation consistent with the notion that this site is largely constitutively phosphorylated. In line with this basal MLC 20 phosphorylation and L-NAME-induced tone was decreased in BA from old mice carrying the T-696A/þ mutation ( Figure 6(a) to (c) ). This genetic knock-in approach to replace T-696 by a non-phosphorylatable alanine resulted in a $40% reduction of T-696 phosphorylation in o-BA (Figure 6 (a) and (b)) further supporting our interpretation that inhibition of MLCP underlies the hypercontractile state of o-BA. The impact of ROK-induced MYPT1-T-853 for regulation of smooth muscle tone has recently been questioned utilizing bladder smooth muscle from mice E 18.5 fetus carrying the T-853A mutation. 58 The authors suggested that the predominant mechanism of MLCP inhibition is phosphorylation of MYPT1 at T-696 which appears to maintain a basal level of Ca 2þ -sensitization. Our results are consistent with this idea but indicate that vascular hypercontractility in aged WT mice additionally involves an increased MYPT1-T-853 phosphorylation. In addition, ROK is involved in increasing actin polymerization that may account for the observed increased F-actin content and contribute to the increased tone. Such an increased availability of F-actin contributing to the force generation independent of increases in MLC 20 , phosphorylation has been demonstrated recently in pressurized rat middle cerebral arteries. 38 Thus, at present, assessment of the relative contribution of the inhibitory phosphorylation of MYPT1 at T-853 or T-696 and actin dynamics in regulation of basal tone in BA remains elusive.
Taken together, the balance between intracellular contracting and relaxing pathways is shifted in o-BA in favor of the former, which can be reversed by apocynin. In this context, it is interesting that aging-induced changes in cerebral blood flow were reversed by in vivo treatment with apocynin in a mouse model of Alzheimer, 4 which could be ascribed to NOX2. 2 In our study, acute application of apocynin decreased the basal tone or phosphorylation of MLC 20 at S-19, but it did not normalize the contractile response to U46619, nor did it restore electrically induced relaxation. These diverging results can be reconciled if one assumed that aging was associated with loss or silencing of perivascular neurons that mediate relaxation, whereas, the basal tone was increased due to acute endothelium-derived signaling events, leading to a ROS-and/or endothelin-mediated increased activity of Rho/ROK with subsequent inhibition of myosin phosphatase in smooth muscle cells. Regardless of the precise mechanism of ROS generation, another interesting observation emerging from the present study is that endothelial denudation in o-BA did not interfere with the lowering of the basal tone by apocynin. This supports the view that non-endothelial cells may be involved in ROS generation, or support the notion that apocynin acts as a ROK inhibitor.
Clinical relevance
Although the extrapolation of our in vitro findings to the in vivo behavior of the brain vasculature has to be done with great caution, two aspects of potential clinical relevance emerged from our findings: First, our finding that transmural electric stimulation is less effective in relaxing o-BA and is counteracting the smooth muscle hypercontractility indicates that any damage of the endothelium will offset the lower limits of autoregulation and endanger blood flow to vital important hind brain areas, but also to subcortical neuronal networks involved in cognitive processing. Given that apocynin reversed the augmented basal tone by disinhibiting MLCP and that it restored NO-sensitivity in o-BA should encourage its evaluation for the treatment of acute or chronic cerebral circulation deficits, at least in in vivo aging animal models. Second, in vivo electrical stimulation of the great petrosal nerve and of the pterygopalatine ganglion as a means to increase cerebral blood flow has been evaluated in a number of animal studies [59] [60] [61] and has recently been suggested as an attractive concept for non-pharmacological treatment of acute stroke. 14 The effectiveness of that treatment is possibly influenced if neurovascular coupling is impaired in the elderly.
Conclusions
The major findings of the present study are (i) we provided evidence for neurovascular uncoupling of BA in old age and for a hypercontractile state of smooth muscle; (ii) both are partially compensated by an upregulation of endothelial NO release; (iii) the hypercontractile state likely is due to inhibition of MLCP, leading to an increase in Ca 2þ -sensitivity and (iv) the increased basal tone, inhibition of MLCP and attenuated NO-sensitivity were prevented by acute application of apocynin, suggesting that these effects are mediated by ROS production. Neurovascular coupling has been investigated in the context of the cerebral microcirculation. As the endothelium appears to compensate in part for this neurovascular uncoupling and for the hypercontractility, damaged endothelium, e.g. in atherosclerosis or as a result of surgical interventions, will favor vasoconstriction and reduce blood supply, especially in the elderly. Hypercontractility and augmented eNOS expression was not found in old mice carrying the T-696A/þ mutation, corroborating the involvement of MLCP inhibition suggesting that targeting phosphorylation of MYPT1 may be a novel treatment option for BA dysfunction in the elderly.
